Four in five asthma deaths may be due to long acting β agonistsBMJ 2006; 332 doi: http://dx.doi.org/10.1136/bmj.332.7556.1467-a (Published 22 June 2006) Cite this as: BMJ 2006;332:1467
- Pat Hagan
Eighty per cent of deaths related to asthma in the United States may be due to the use of long acting β agonists, indicate the results of a meta-analysis of 19 clinical trials.
The results of the review, published in the Annals of Internal Medicine (2006;144; 901-12), have led to calls for the drugs to be withdrawn from the US market.
“We can show that overall it is statistically significant that, compared with patients taking a placebo, these long acting β agonists kill a lot …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial